Sexy Survivors Raise Colorectal Cancer Awareness
Thirteen beautiful men and women raise awareness about an ugly topic: colorectal cancer. These sexy survivors are showing their scars hoping to save lives.
click here to read full article...KRAS is Key to Choosing Colorectal Cancer Chemotherapy
Picking the right drugs to treat colon cancer may depend on the type of KRAS genes in the tumor. Experts are now saying advance testing is the way to go.
click here to read full article...Real Men Ads Give Guys Good Advice for Preventing Cancer
The US Department of Health and Human Services’ Agency for Healthcare Research and Quality (AHRQ) and the Ad Council have launched a national ad campaign encouraging men over 40 to take an active role in their own health care.
The Real Men Wear Gowns campaign, which was created pro bono by McCann Erickson Detroit, [...]
UCLA Kills Cancer Cells With Light-Activated Nanoimpeller
Scientists at the University of California, Los Angeles (UCLA) have developed a new light-activated nanomachine which can store anticancer drugs and release them into cancer cells.
Researchers from the California NanoSystems Institute and the Jonsson Comprehensive Cancer Center at UCLA created the tiny cargo-carrying nanoparticles as a mechanism to deliver targeted chemotherapy drugs or dyes [...]
Wake Forest Finds Oxaliplatin Dosage for Peritoneal Cancer
Researchers from Wake Forest University have completed a Phase I study that may help improve the survival rate for patients with appendix cancer or colorectal cancer that’s spread to their abdomen.
Wake Forest’s study identified the maximum amount of a chemotherapy drug peritoneal cancer patients can successfully tolerate during Intraperitoneal Hyperthermic Chemotherapy (IPHC) treatments following [...]
New Colorectal Cancer Guidelines Focus on Prevention
Representatives from five major US cancer care groups have collaborated to create new colorectal cancer screening guidelines designed to detect precancerous adenomas and malignant tumors in patients showing no symptoms.
The American Cancer Society, the American College of Gastroenterology, the American Gastroenterological Association, the American Society for Gastrointestinal Endoscopy and the American College of Radiology weighed [...]
Rochester Recommends Earlier Colonoscopies for Smokers
A study of 3,450 colorectal cancer patients conducted by the University of Rochester Medical Center suggests smokers should start getting screened for colon cancer 10 years earlier than their non-smoking counterparts.
The American Cancer Society and other cancer experts currently recommend most people begin getting colonoscopies at age 50. However, Rochester’s investigation indicates age [...]
John Wayne Ties CCR9 to Metastatic Melanoma in GI Tract
Research conducted by the John Wayne Cancer Institute (JWCI) at Saint John’s Health Center indicates the receptor protein CCR9 may promote the spread of melanoma to the small intestine.
Unlike other cancers, melanoma skin cancer commonly metastasizes to the lower bowel and, until recently, scientists were at a loss to explain the connection. JWCI’s [...]
Europe OKs Oral Chemo for Advanced Colorectal Cancer
Patients being treated for metastatic colorectal cancer in Europe just got a new treatment option.
Capecitabine, which is marketed by Switzerland-based pharmaceutical company Roche under the trade name Xeloda, has been approved by the European Commission for the treatment of metastatic colorectal cancer.
European health officials approved the oral tablets for use in combination with any chemotherapy [...]
Aetna Ends Coverage for Anesthetic Used in Colonoscopies
Effective April 1, 2008, Aetna (NYSE: AET) will no longer cover an anesthetic commonly used during colonoscopies, a diagnostic tool used to detect colorectal cancer. Similar exclusions have already been implemented by WellPoint (NYSE: WLP) and Humana (NYSE: HUM).
The drug propofol, marketed under the trade name Diprivan, is used to thoroughly [...]


